TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,385
|
1,220
|
1,260 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
749
|
342
|
214 |
| EBITDA |
716
|
340
|
214 |
| Total assets |
2,251
|
2,072
|
2,327 |
| Current assets |
2,251
|
2,072
|
2,327 |
| Current liabilities |
24
|
14
|
190 |
| Equity capital |
2,168
|
1,996
|
2,072 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
96.3%
|
96.3%
|
89.0% |
| Turnover per employee |
1,385
|
1,220
|
1,260 |
| Profit as a percentage of turnover |
54.1%
|
28.0%
|
17.0% |
| Return on assets (ROA) |
33.3%
|
16.5%
|
9.2% |
| Current ratio |
9379.2%
|
14800%
|
1224.7% |
| Return on equity (ROE) |
34.5%
|
17.1%
|
10.3% |
| Change turnover |
78
|
-2
|
-579 |
| Change turnover % |
6%
|
0%
|
-31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.